Atlas Trials

Role of Geminin and Mcm-2 in Prognosis of Renal Cell Carcinoma

Clinical trial NCT03692533 · UNKNOWN

Trial details

NCT number
NCT03692533
Sponsor
Assiut University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Renal Cell Carcinoma
Start date
2018-10-01
Primary completion
2020-10-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.